Last reviewed · How we verify
albendazole plus praziquantel regime — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
albendazole plus praziquantel regime (albendazole plus praziquantel regime) — Universidad Peruana Cayetano Heredia.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| albendazole plus praziquantel regime TARGET | albendazole plus praziquantel regime | Universidad Peruana Cayetano Heredia | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- albendazole plus praziquantel regime CI watch — RSS
- albendazole plus praziquantel regime CI watch — Atom
- albendazole plus praziquantel regime CI watch — JSON
- albendazole plus praziquantel regime alone — RSS
Cite this brief
Drug Landscape (2026). albendazole plus praziquantel regime — Competitive Intelligence Brief. https://druglandscape.com/ci/albendazole-plus-praziquantel-regime. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab